Federal Supply Schedule 36F79723D0237
Award Date
10/1/23
Last Date to Order
9/30/28
Federal Agency
Veterans Integrated Service Network 12
Awardee
Acadia Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Civicascript LLC, a non-profit limited liability company. The contract, valued at a ceiling of $225,000.00, is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA and has a period of performance through August 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows ordering from...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acacia Pharma, Inc. The contract is for Pharmaceuticals and Drugs (FSS-61-IB) and has a ceiling value of $225,000.00 with a period of performance through June 14, 2026. This FSS contract enables the VA to procure a range of pharmaceutical and hematology-related products from Acacia Pharma, Inc. The contract was awarded on a multiple award basis, meaning other...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Acelrx Pharmaceuticals, Inc., a for-profit manufacturer of goods. The contract provides pharmaceuticals and drugs under GSA Schedule 65 IB, with a potential value of $250,000. The period of performance is from August 15, 2019 through the last date to order of August 14, 2024. The contract aims to procure drugs, pharmaceuticals, and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 12, to Aquestive Therapeutics, Inc., a for-profit manufacturer of goods and subchapter S corporation. The contract, which has a maximum value of $25,000.00 and a period of performance through March 31, 2025, provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract is a multiple...
The Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Nextgen Pharmaceuticals LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. With a potential value of $400,000 and a period of performance through July 2028, the multiple award contract aims to meet the healthcare needs of veterans through the procurement of pharmaceuticals and...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs to Intra-Cellular Therapies, Inc., a for-profit small disadvantaged business. The contract provides access to a range of drugs, pharmaceuticals, and hematology-related products under the 65 I B Federal Supply Schedule contract. The contract has a ceiling value of $24,000,000 and a period of performance through September 30, 2026. The contract was awarded on October 1, 2020 without the use of any set-asides....
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to Accord Biopharma, Inc., a foreign-owned for-profit organization. The contract has a ceiling value of $300,000.00 and a period of performance through December 14, 2027. The contract is for the addition of pharmaceutical and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The specific products and services to be...
The provided information details a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Acertis Pharmaceuticals LLC. The contract, identified as 36F79723D0216, is for the procurement of Drugs, Pharmaceuticals, & Hematology Related Products (FSC 65 I B) and has a ceiling value of $6,690,000.00. The contract was awarded on September 29, 2023, with a performance period extending through September 28, 2028. Acertis Pharmaceuticals LLC, a for-profit limited...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...